Search

Displaying results 6251 - 6260 of 10000 in total
  1. Drug

    Lodiperone

    go.drugbank.com/drugs/DB21210
    Experimental

    Lodiperone has a monoisotopic molecular weight of 435.09 Da. … Lodiperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Lodiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  2. Drug

    Murocainide

    go.drugbank.com/drugs/DB21243
    Experimental

    Murocainide has a monoisotopic molecular weight of 377.2 Da. … Murocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Murocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  3. Drug

    Zocainone

    go.drugbank.com/drugs/DB21326
    Experimental

    Zocainone has a monoisotopic molecular weight of 353.2 Da. … Zocainone is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Zocainone is a class I antiarrhythmic, procainamide and lidocaine derivative.

  4. Drug

    Atrimustine

    go.drugbank.com/drugs/DB21376
    Experimental

    Atrimustine has a monoisotopic molecular weight of 719.28 Da. … Atrimustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Atrimustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  5. Drug

    Pirenperone

    go.drugbank.com/drugs/DB21405
    Experimental

    Pirenperone has a monoisotopic molecular weight of 393.19 Da. … Pirenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Pirenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  6. Drug

    Cinsebrutinib

    go.drugbank.com/drugs/DB21640
    Experimental

    Cinsebrutinib has a monoisotopic molecular weight of 383.2 Da. … Cinsebrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  7. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax has a monoisotopic molecular weight of 1038.41 Da. … Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  8. Drug

    Metiamide

    go.drugbank.com/drugs/DB08805
    Experimental

    Metiamide is an H-2 receptor antagonist derived from burimamide. It was an intermediate product on the path to developing cimetidine.

  9. Drug

    DG051

    go.drugbank.com/drugs/DB05177
    Experimental

    DG051 is designed to decrease risk of heart attack by decreasing the production of leukotriene B4 (LTB4), an end product of the leukotriene pathway and a potent promoter of inflammation. … DG051 is a novel small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H), the protein made by one of the genes in the leukotriene pathway that has been shown to link to risk of heart attack.

  10. Drug

    Imidafenacin

    go.drugbank.com/drugs/DB09262
    Investigational

    Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder.